Key Insights

Highlights

Success Rate

71% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 72/100

Termination Rate

15.2%

7 terminated out of 46 trials

Success Rate

70.8%

-15.7% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

18%

3 of 17 completed with results

Key Signals

3 with results71% success

Data Visualizations

Phase Distribution

34Total
Not Applicable (19)
Early P 1 (1)
P 1 (10)
P 2 (4)

Trial Status

Completed17
Recruiting13
Terminated7
Not Yet Recruiting6
Unknown2
Active Not Recruiting1

Trial Success Rate

70.8%

Benchmark: 86.5%

Based on 17 completed trials

Clinical Trials (46)

Showing 20 of 20 trials
NCT04565457Not ApplicableCompleted

A Pilot Study Evaluating the Effect of 2D Antiscatter Grids on CBCT Image Quality

NCT06676943Not ApplicableCompleted

Investigating the Diagnostic Performance of High-resolution Specimen PET-CT in Determining Margin Status in Cancer Resection

NCT07462377Phase 1Recruiting

A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC

NCT07241273Not ApplicableNot Yet Recruiting

SPECT-CT Guided ELEctive Contralateral Neck Treatment in Lateralized Oropharyngeal Cancer

NCT02997332Phase 1TerminatedPrimary

Durvalumab in Combination With Docetaxel, Cisplatin and 5-FU for Locally Advanced Head and Neck Squamous Cell Carcinoma

NCT06681233Not ApplicableRecruitingPrimary

Feasibility Study of CBCT for IGRT in Cancer Patients

NCT06910657Phase 1Recruiting

IDOV-Immune for Advanced Solid Tumors

NCT07437326Not Yet Recruiting

Food-related Quality of Life in Patients With Cancer

NCT05787587Phase 1Recruiting

A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid Tumors

NCT06472726Not ApplicableTerminated

Mental Health App for Cancer Survivors Study

NCT03556228Phase 1Recruiting

VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

NCT06771336RecruitingPrimary

Biomedical Innovation for Facial Bone Reconstruction in Oncology: BIOFACE PASS a Medico-economic Study Describing the Standard Pathway of Patients Treated by Free Bone Flap

NCT05272917Not ApplicableCompletedPrimary

SOMESThesia and ALIMentation

NCT06638216Not ApplicableCompletedPrimary

Prospective Evaluation of Frailty in Patients With Head and Neck Tumors Before Curative Intended Therapy

NCT06940505Not ApplicableRecruitingPrimary

Telemedicine Follow-Up for Early Laryngeal Cancer: a Randomized Controlled Trial Comparing Care Close to Home Versus Standard of Care

NCT07108517Not ApplicableRecruiting

A Manualized Post-Traumatic Growth Intervention for People With Cancer in Greece - IC-Growth

NCT00568490Recruiting

Identification of Secreted Markers for Tumor Hypoxia in Patients With Head and Neck or Lung Cancers

NCT06870799Not ApplicableRecruitingPrimary

Comparing Closed Face Masks vs Surface Guided Radiation Therapy for Head and Neck Radiotherapy

NCT06894459Phase 2Not Yet RecruitingPrimary

A Prospective, Multicenter, Multicohort Phase II Study: Evaluating the Efficacy and Safety of Preoperative Neoadjuvant Treatment With a PD-1 Inhibitor in Combination With Chemotherapy in Locally Advanced Laryngeal and Hypopharyngeal Squamous Cell Carcinoma

NCT06896448Not ApplicableNot Yet Recruiting

Innovative OSA Screening in Head and Neck Cancer Patients With the Apneal App

Scroll to load more

Research Network

Activity Timeline